Tag: NASDAQ:MGI

  • Bearish Stocks: Walter Energy (NYSE:WLT), Lululemon Athletica inc. (NASDAQ:LULU), Moneygram International (NASDAQ:MGI), IsoRay, Inc. (NYSEMKT:ISR)

    The gross profit margin for Walter Energy, Inc. (NYSE:WLT) is rather low; currently it is at 17.54%. Despite the low profit margin, it has increased significantly from the same period last year. Despite the mixed results of the gross profit margin, WLT’s net profit margin of -36.93% significantly underperformed when compared to the industry average. Walter Energy, Inc. (NYSE:WLT) shares after opening at $7.55 moved to $7.65 on last trade day and at the end of the day closed at $7.24. Company price to sales ratio in past twelve months was calculated as 0.24 and price to cash ratio as 1.74. Walter Energy, Inc. (NYSE:WLT) showed a negative weekly performance of -1.76%.

    Lululemon Athletica Inc. (NASDAQ:LULU) fell the most in more than three months after an analyst at Sterne Agee & Leach Inc. said the yoga-wear retailer didn’t provide a clear strategy for improving sales at a recent presentation. Lululemon Athletica inc. (NASDAQ:LULU) shares fell -5.11% in last trading session and ended the day on $49.07. LULU return on equity ratio is recorded as 32.30% and its return on assets is 28.50%. Lululemon Athletica Inc. (NASDAQ:LULU) yearly performance is -28.24%.

    Walmart already has a partnership with MoneyGram International Inc. (NASDAQ:MGI) to offer money transfers, and will continue to maintain that business, though it will likely recommend MoneyGram’s services to customers who need to transfer more than $900 at a time, which is the limit for Ria’s services. Moneygram International Inc. (NASDAQ:MGI) shares moved down -13.57% in last trading session and was closed at $12.80, while trading in range of $12.45 – $14.68. Moneygram International Inc. (NASDAQ:MGI) year to date (YTD) performance is -38.40%.

    IsoRay Inc. (NYSEMKT:ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, on 7 April announced the first prostate cancer implant combining IsoRay’s Cesium-131 seeds with C4 Imaging’s Sirius® positive signal MRI markers. IsoRay, Inc. (NYSEMKT:ISR) weekly performance is -18.57%. On last trading day company shares ended up $2.28. IsoRay, Inc. (NYSEMKT:ISR) distance from 50-day simple moving average (SMA50) is 40.93%. Analysts mean target price for the company is $3.50.